Licence Right-Sizing: $1.2M Reclaimed for Fortune 500 Pharmaceutical

The Challenge

A Fortune 500 pharmaceutical company had operated their ServiceNow platform for 7 years without formal licence governance. During that time, the platform had grown organically across multiple business units, with different divisions purchasing modules and fulfillers based on perceived needs rather than actual usage.

The result was a complex, sprawling deployment with significant waste: 20 percent of fulluser licences were unused or inactive, and module tier assignments were misaligned with how teams actually used the system. When they approached their renewal, they had no clarity on what they were actually paying for—or what they could eliminate.

The Audit: Identifying the Waste

We conducted a comprehensive licence estate audit across their entire ServiceNow deployment. The findings were stark:

• 340 unused fulfillers—These were licences assigned to active users who hadn't logged in for 6+ months or were assigned to dormant accounts within the system.
• 30 to 40 percent module over-tier cost—Many modules were licensed at tiers significantly higher than what the actual user population needed. Example: A team of 15 users was licensed for a high-tier module when their workflows required mid-tier capabilities.
• No usage data governance—The company had no process to regularly review who was actually using what, allowing inactive accounts and unused licences to accumulate year after year.

Why Timing Matters: Pre-Renewal Right-Sizing

This is a critical point: right-sizing before renewal is when you have maximum leverage. If you approach ServiceNow at renewal saying "we want to eliminate 340 fulfillers and downgrade modules," they can factor those changes into the renewal quote. If you try to negotiate these changes after renewal, you're negotiating mid-contract amendments, which have different mechanics and lower urgency.

This client caught the issue in time—they discovered the waste problem 10 months before renewal. That window was critical to their success.

Our Approach: Three-Phase Right-Sizing

Phase 1: Fulluser Licence Rationalisation

We worked with their IT and business teams to identify which of the 340 unused fulfillers could be safely eliminated. Not all inactive accounts represent pure waste—some are reserved for seasonal staff or kept for contingency. We conducted interviews with business stakeholders to determine which accounts were genuinely unnecessary and which needed to be retained. The outcome: 340 fulfillers eliminated at a cost of approximately $600K annually.

Phase 2: Module Tier Analysis and Right-Sizing

We audited their module portfolio and assessed tier assignments against actual user workflows and system configurations. Many modules had been licensed at higher tiers than necessary. For example, some teams were paying for advanced reporting features they weren't using. We created a tiering recommendation that maintained all required capabilities while moving 30 to 40 percent of module spend to more appropriate tiers. This represented approximately $600K in additional annual savings.

Phase 3: Governance Framework

Right-sizing is only effective if governance prevents future waste. We helped establish a quarterly licence review process where active user counts, module usage patterns, and tier appropriateness are assessed. This framework ensures they won't slip back into waste in future years.

Implementation and Results

The pharmaceutical company incorporated these changes into their renewal negotiation. Instead of renewing at existing spend levels with a vendor uplift, they renewed with a significantly reduced licence footprint that reflected their actual needs. The result: $1.2M in reclaimed annual spend.

Equally important, they now have a baseline understanding of their licence portfolio. The 340 eliminated fulfillers and module tier rationalisation created clarity around what features and user counts are actually delivering business value. This baseline will inform their usage planning for future renewals.

The Business Impact Beyond Dollar Savings

The direct financial savings are significant, but the secondary benefits matter equally. The pharmaceutical company now has:

• Licence visibility. They can articulate which modules, editions, and user counts are essential to their operations.
• Governance mechanisms. Quarterly reviews prevent future accumulation of unused licences.
• Data-driven renewal positioning. When their next renewal approaches, they'll negotiate from documented current-state baseline, not guesses about usage.

Key Lessons on Licence Right-Sizing

• Right-size before renewal, not after. The window to eliminate unused licences and downgrade tiers is when a renewal is approaching. Once you've renewed, mid-contract amendments are harder to negotiate.
• Unused fulfillers compound over years. Without governance, 1 to 2 percent of your user base becomes inactive each year. Over 7 years, that compounds to 15 to 20 percent waste. Regular audits catch this.
• Module tier misalignment is common. Teams often inherit tier assignments based on "what the vendor recommended" rather than what they actually use. Feature-level audit is essential.
• Governance prevents future waste. Right-sizing is a one-time benefit unless you establish ongoing processes to review usage, user counts, and tier appropriateness.
• Multiple levers create leverage. Combining fulluser elimination, module tier reductions, and a demonstrated governance framework gives you multiple negotiating positions with ServiceNow.

About the Client

A Fortune 500 pharmaceutical company with global operations across drug development, manufacturing, regulatory affairs, and commercial distribution. Their ServiceNow platform supports IT service management, change management, and incident management across multiple divisions and geographies. The platform had grown without centralised licence governance for 7 years.